Long-term Safety and Efficacy of Subcutaneous Immunoglobulin IgPro20 in CIDP: The PATH Extension Study

被引：0
|
作者：
Mielke, Orell [1 ]
van Schaik, Ivo [2 ]
Bril, Vera [3 ]
van Geloven, Nan [4 ]
Hartung, Hans-Peter [5 ]
Lewis, Richard [6 ]
Sobue, Gen [7 ]
Lawo, John-Philip [1 ]
Praus, Michaela [1 ]
Durn, Billie [1 ]
Cornblath, David [8 ]
Merkies, Ingemar [9 ]
机构：
[1] CSL Behring, King Of Prussia, PA USA
[2] Univ Amsterdam, Amsterdam, Netherlands
[3] Univ Toronto, Toronto, ON, Canada
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
[5] Heinrich Heine Univ, Dusseldorf, Germany
[6] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[7] Nagoya Univ, Nagoya, Aichi, Japan
[8] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[9] Maastricht Univ, Med Ctr, Maastricht, Netherlands
来源：
ANNALS OF NEUROLOGY | 2018年 / 84卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
M275
引用
收藏
页码：S218 / S218
页数：1
相关论文
共 50 条
  • [21] Treatment satisfaction and work productivity in a clinical study of IgPro20 maintenance treatment of CIDP
    Hartung, Hans-Peter
    Mallick, Rajiv
    Bril, Vera
    van Geloven, Nan
    Lewis, Richard
    Sobue, Gen
    Lawo, John-Philip
    Mielke, Orell
    Durn, Billie
    Comblath, David
    Merkies, Ingemar
    van Schaik, Ivo
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 330 - 330
  • [22] IgPro20, the Polyneuropathy and Treatment with Hizentra® study (PATH), and the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with subcutaneous IgG
    Berger, Melvin
    Harbo, Thomas
    Cornblath, David R.
    Mielke, Orell
    IMMUNOTHERAPY, 2018, 10 (11) : 919 - 933
  • [23] Subcutaneous Immunoglobulin Therapy with IgPro20 in Patients with Stiff Person Syndrome and Primary Immunodeficiency Disease
    Francis, Olivia L.
    Joshi, Avni
    Prince, Ty
    Krishnaswamy, Guha
    Patel, Niraj C.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (06) : 973 - 977
  • [24] Cost-minimization Analysis of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients With Primary Immunodeficiency
    Igarashi, Ataru
    Kanegane, Hirokazu
    Kobayashi, Midori
    Miyawaki, Toshio
    Tsutani, Kiichiro
    CLINICAL THERAPEUTICS, 2014, 36 (11) : 1616 - 1624
  • [25] SUBCUTANEOUS IMMUNOGLOBULIN IN CIDP AND MMN: A DIFFERENT LONG-TERM CLINICAL RESPONSE?
    Merola, A.
    Cocito, D.
    Romagnolo, A.
    Peci, E.
    Toscano, A.
    Mazzeo, A.
    Gentile, L.
    Russo, M.
    Fazio, R.
    Filosto, M.
    Siciliano, G.
    Schirinzi, E.
    Lopiano, L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 : S19 - S20
  • [26] Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?
    Cocito, Dario
    Merola, Aristide
    Romagnolo, Alberto
    Peci, Erdita
    Toscano, Antonio
    Mazzeo, Anna
    Gentile, Luca
    Russo, Massimo
    Fazio, Raffaella
    Filosto, Massimiliano
    Siciliano, Gabriele
    Schirinzi, Erica
    Nobile-Orazio, Eduardo
    Lopiano, Leonardo
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (07): : 791 - U136
  • [27] A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY EVALUATING THE EFFICACY, SAFETY AND PHARMACOKINETICS OF IGPRO20 (SUBCUTANEOUS IMMUNOGLOBULIN) IN ADULTS WITH DERMATOMYOSITIS: RECLAIIM STUDY DESIGN
    Schmidt, Jens
    Aggarwal, Rohit
    Werth, Victoria P.
    Benveniste, Olivier
    Kohsaka, Hitoshi
    Friede, Tim
    Praus, Michaela
    Mielke, Orell
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 488 - 489
  • [28] SUBCUTANEOUS IMMUNOGLOBULIN IN CIDP AND MMN: A DIFFERENT LONG-TERM CLINICAL RESPONSE?
    Peci, E.
    Merola, A.
    Romagnolo, A.
    Toscano, A.
    Mazzeo, A.
    Gentile, L.
    Russo, M.
    Fazio, R.
    Filosto, M.
    Siciliano, G.
    Schirinzi, E.
    Nobile-Orazio, E.
    Lopiano, V
    Cocito, D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 208 - 209
  • [29] Annual meeting of European Society for Immunodeficiencies (ESID) New subcutaneous immunoglobulin IgPro20 shows good effectiveness and safety in studies
    Pyko, Martina
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2011, 38 (01)
  • [30] HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN 10% FOR CIDP: FINAL RESULTS FROM A LONG-TERM SAFETY AND TOLERABILITY STUDY
    Hadden, Robert
    Andersen, Henning
    Bril, Vera
    Basta, Ivana
    Rejdak, Konrad
    Duff, Kim
    Greco, Erin
    Hasan, Shabbir
    Anderson-Smits, Colin
    Ay, Hakan
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S78 - S79
12345